Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s):  CSCI

Healthcare Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:CSCI)

COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

GlobeNewswire August 27, 2024

COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results

GlobeNewswire August 13, 2024

Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.

GlobeNewswire August 6, 2024

Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders

GlobeNewswire July 16, 2024

Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

GlobeNewswire June 13, 2024

Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders

PR Newswire June 7, 2024

Aeterna Zentaris and Ceapro Complete Merger Transaction

GlobeNewswire June 3, 2024

Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date

GlobeNewswire May 29, 2024

Aeterna Zentaris Announces Details Regarding Transaction with Ceapro

GlobeNewswire May 17, 2024
View More News ››

Opinion & Analysis (TSX:CSCI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:CSCI)

Fibrosis and mortality

The assertion that fibrotic disorders could account for up to 45% of deaths in the United States is...
prophetoffactz - 13 hours ago

Wound healing franchise

Based on Ceapro's recent research and published results, a wound healing franchise appears to be a compelling and promising direction...
prophetoffactz - 17 hours ago

Cancer Cachexia

AEZS has run a small pilot study on macimorelin to treat cancer cachexia. "Roughly 19.3 million people globally were diagnosed with...
prophetoffactz - 1 day ago

RE:Diclofenac

Based on the research, combining diclofenac with PGX-YBG might also be beneficial for: Chronic wound management Inflammatory...
prophetoffactz - 1 day ago

Diclofenac

One drug that Gilles said they were trying to incorporate into a PGX carrier is diclofenac. That was...
prophetoffactz - 1 day ago

PGX-YBG/Avenanthramide for periodontal disease?

Here's Perplexity Ai's take: Ceapro's yeast beta glucan impregnated with avenanthramide presents a promising approach to...
prophetoffactz - 2 days ago
View more Bullboard ››

Riley Gold Corp.

Riley Gold Corp.

Riley Gold Corp. is a gold exploration company with projects within major gold bearing trends in the state of Nevada. The ...
View More »